Perfect! I have the data I need. Now let me create the article based on the analyst changes data showing stocks with high analyst activity and significant return potentials.
MSFT Microsoft drew intense analyst attention. The $2.8T software giant shows 57% upside to consensus targets. The stock fell 23% year to date creating opportunity. Analysts see value despite market pressure.
NKE Nike commands 48% analyst upside potential. The $65B apparel maker dropped 31% this year. RSI hit just 20 showing extreme oversold conditions. Wall Street sees recovery ahead for the athletic brand.
PHR Phreesia grabbed massive 102% upside from analysts. The health tech name crashed 51% in 2026. Bears hold modest positions with 1.7 days to cover. Street consensus signals deep value at current levels.
Biotech draws mixed views. APLS Apellis Pharmaceuticals shows negative 4% analyst return despite surging 61% year to date. The $5.2B drugmaker faces skepticism after sharp gains. Short score remains elevated at 65.
GE General Electric holds 26% upside. The $294B aerospace giant fell 9% as defense sector rotated. Analysts maintain conviction on aerospace recovery themes.
Beaten down names dominate positive outlooks. Analysts favor stocks hit hardest by 2026 volatility.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
